Track topics on Twitter Track topics that are important to you
PharmSource: Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2023
This report is the 6th edition of our longrunning analysis of the injectables CMO industry. It provides an expert quantitative analysis on the latest trends and plans for outsourcing commercially approved injectable products. It combines the rich data resources of PharmSource and the GlobalData Pharmaceutical Intelligence Center with our 20 years' experience in analyzing the injectables CMO industry to provide the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
The report is based on the most recent data on industry capacity, the injectables pipeline and the behaviors of the key biopharmaceutical industry actors.
The model and assumptions are fully explained so you can understand how the analysis was driven and how conclusions were reached.
Reasons to buy
This 70page report gives important, expert insight you won't find in any other source. Over 25 tables and graphs throughout the report illustrate major points and trends. This report is required reading for
CMO executives who must have deep understanding of the injectables marketplace to make strategic planning and investment decisions.
Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.NEXT ARTICLE
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...